XML 57 R45.htm IDEA: XBRL DOCUMENT v3.5.0.2
Segment Reporting (Selected Financial Information by Reporting Segment) (Details)
$ in Thousands, € in Millions
3 Months Ended 9 Months Ended 30 Months Ended
Sep. 30, 2016
USD ($)
Sep. 30, 2015
USD ($)
Sep. 30, 2016
USD ($)
segment
Sep. 30, 2016
EUR (€)
segment
Sep. 30, 2015
USD ($)
Sep. 30, 2016
EUR (€)
Segment Reporting Information [Line Items]            
Number of Reportable Segments | segment     2 2    
Net revenues:            
Net Revenue $ 64,223 $ 63,868 $ 191,622   $ 174,607  
Gross Profit:            
Gross Profit 27,612 17,578 84,228   44,176  
Operating expenses 21,815 21,326 64,026   65,445  
Income (loss) from operations 5,797 (3,748) 20,202   (21,269)  
Non-operating income (expenses) 204 (528) (633)   567  
Income (loss) before income taxes 6,001 (4,276) 19,569   (20,702)  
Finished Pharmaceutical Products            
Net revenues:            
Net Revenue 59,058 57,902 181,368   158,849  
Gross Profit:            
Gross Profit 28,621 19,302 85,042   44,789  
API            
Segment Reporting Information [Line Items]            
Remediation expense incurred in connection with API acquisition | €       € 0.6   € 0.6
Environmental remediation threshold provided by Merck for expenses incurred | €       € 6.0    
Net revenues:            
Net Revenue 5,165 5,966 10,254   15,758  
Gross Profit:            
Gross Profit $ (1,009) $ (1,724) $ (814)   $ (613)